- content
Theorist argument for 'ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local':
The hypothesis is mechanistically plausible because it names ubiquitylation-dependent turnover / ubiquitylation-dependent turnover as an upstream, testable driver in neurodegeneration, not merely a downstream correlate. The stated experimental logic is: The gap can be tested by treating ubiquitylation-dependent turnover as an upstream driver rather than a passive correlate. If true, perturbing E3 ligase mapping should shift UBQLN2 puncta lifetime before downstream neurodegeneration markers change.
Supporting evidence read before debate:
- four_round_gap_debate [four_round_gap_debate]
- TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]
- Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]
- Neurotrophins and neurodegeneration. [12787319]
The strongest version of the claim is falsifiable: an intervention or stratification that shifts the ubiquitylation-dependent turnover readout should precede measurable changes in downstream neurodegeneration markers. The hypothesis also has practical value because it identifies a biomarker or perturbation axis that can be measured longitudinally rather than relying on cross-sectional association alone.
- evidence_cited
["four_round_gap_debate [four_round_gap_debate]", "TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]", "Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]", "Neurotrophins and neurodegeneration. [12787319]"]
- argument
Theorist argument for 'ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local':
The hypothesis is mechanistically plausible because it names ubiquitylation-dependent turnover / ubiquitylation-dependent turnover as an upstream, testable driver in neurodegeneration, not merely a downstream correlate. The stated experimental logic is: The gap can be tested by treating ubiquitylation-dependent turnover as an upstream driver rather than a passive correlate. If true, perturbing E3 ligase mapping should shift UBQLN2 puncta lifetime before downstream neurodegeneration markers change.
Supporting evidence read before debate:
- four_round_gap_debate [four_round_gap_debate]
- TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]
- Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]
- Neurotrophins and neurodegeneration. [12787319]
The strongest version of the claim is falsifiable: an intervention or stratification that shifts the ubiquitylation-dependent turnover readout should precede measurable changes in downstream neurodegeneration markers. The hypothesis also has practical value because it identifies a biomarker or perturbation axis that can be measured longitudinally rather than relying on cross-sectional association alone.
- evidence
["four_round_gap_debate [four_round_gap_debate]", "TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. [33031745]", "Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. [30643298]", "Neurotrophins and neurodegeneration. [12787319]"]